期刊文献+

胃癌复发、转移诊治难点与对策 被引量:20

Difficulties and countermeasures of the diagnosis and treatment for gastric cancer patients with metastasis and recurrence
原文传递
导出
摘要 积极预防与治疗胃癌复发、转移是提高胃癌整体疗效的关键。外科医生应充分了解肿瘤复发、转移的病理生物学特征,并积极推广分子病理分型工作;应更加重视对肿瘤复发、转移的预防性治疗,采取积极的围手术期综合治疗;强调首次手术的规范性与根治性,减少并杜绝医源性肿瘤复发;对复发、转移病人坚持积极的综合治疗,以争取理想的疗效。 More active strategies of prevention and treatment are the keys to improving the prognosis for gastric cancer patients with metastasis or recurrence. Based on a lot of clinical experience, surgeons should focus on full understanding of the bio-pathological behavior of tumor metastasis and recurrence and actively promoting the molecular pathological classification in the clinical diagnosis. Surgeons should pay more attention to preventive treatment for tumor metastasis and recurrence, especially to the perioperative comprehensive treatment. The normative and radical principle for the first radical surgery should be emphasized to eliminate iatrogenic tumor recurrence as far as possible. Keeping comprehensive therapeutic strategies for patients with tumor metastasis and recurrence aimed at striving for the ideal outcome.
作者 朱正纲
出处 《中国实用外科杂志》 CSCD 北大核心 2015年第10期1037-1039,1045,共4页 Chinese Journal of Practical Surgery
关键词 胃癌 复发 转移 gastric cancer recurrence ,metastasis
  • 相关文献

参考文献14

  • 1胃癌病理分型和诊断标准的建议[J].中华病理学杂志,2010,39(4):266-269. 被引量:115
  • 2The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma [J]. Na- ture, 2014, 53(7517):202-209.
  • 3Cristescu R, Lee J, Nebozhyn M, et al. Molecular analysis of gas- tric cancer identifies subtypes associated with distinct clinical outcomes[J]. Nat Med, 2015, 21:449-456.
  • 4胡祥.胃癌的临床分期及其重要意义[J].中国实用外科杂志,2011,31(8):652-656. 被引量:24
  • 5梁寒.影响胃癌预后因素研究进展[J].中国实用外科杂志,2011,31(8):726-729. 被引量:17
  • 6Yonemura Y, Elnemr A, Endou Y, et al. Effects of neoadjuvant intraperitoneaUsystemic chemotherapy (bidirectional chemother- apy) for the treatment of patients with peritoneal metastasis from gastric cancer[J]. Inter J Surg Oncol, 2012,2012: 148420.
  • 7Zhu ZG, Tang R, Yan M, et al. Efficacy and safety of intraopera- tive peritoneal hyperthermic chemotherapy for advanced gastric cancert patients with serosal invasion [J]. Dig Surg, 2006, 23(2): 93-102.
  • 8Kuramoto M, Shimada S, Ikeshima S, et al. Extensive intraopera- tire peritoneal lavage as a standard prophy-lactic strategy for peritoneal recurrence in patients with gastric carcinoma[J]. Ann Surg, 2009, 250(2):242-246.
  • 9Lehnert T, Rudek B, Buhl K, et al. Surgical therapy for loco-re- gional recurrence and distant metastasis of gastric cancer [J]. Eur J Surg Oncol, 2002, 28(4):455-461.
  • 10Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised na- tionwide Dutch D1D2 trial [J]. Lancet Oneal, 2010, 11(5): 439-449.

二级参考文献35

  • 1Lauren P.The two histological main types of gastric carcinoma:diffuse and so-called intestinal-type carcinoma.An attempt at a histo-clinical classification.Acta Pathol Microbiol Scand,1965,64:31-49.
  • 2Schlemper R J,Itabeshi M,Kato Y,et al.Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists.Lancet,1997,349(9067):1725-1729.
  • 3Ichikura T,Tomimatsu S,Uefuji K,et al.Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification.Cancer,1999,86(4):553-558.
  • 4Hamilton SR,Aaltonen LA.World Health Organization classification of tumours.Pathology and genetics of turnouts of the digestive system.Lyon:IARC Press,2000.
  • 5Zheng H,Takahashi H,Murai Y,et al.Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan:an immunostaining study on the tissue microarray.J Clin Pathol,2007,60(3):273-277.
  • 6Solcia E,Klersy C,Mastracci L,et al.A combined histo]ogic and molecular approach identifies three groups of gastric cancer with different prognosis.Vircbews Arch,2009,455(3):197-211.
  • 7Ugwuji N. Maduekwe MD, MMSc,Gregory Y. Lauwers MD,Carlos Fernandez-del-Castillo MD,David L. Berger MD,Charles M. Ferguson MD,David W. Rattner MD,Sam S. Yoon MD.New Metastatic Lymph Node Ratio System Reduces Stage Migration in Patients Undergoing D1 Lymphadenectomy for Gastric Adenocarcinoma[J]. Annals of Surgical Oncology . 2010 (5)
  • 8Jingyu Deng MD,Han Liang MD,Dan Sun MS,Dianchang Wang MD,Yi Pan MD.Suitability of 7th UICC N Stage for Predicting the Overall Survival of Gastric Cancer Patients After Curative Resection in China[J]. Annals of Surgical Oncology . 2010 (5)
  • 9Jingyu Deng MD,Han Liang MD,Dianchang Wang MD,Dan Sun MS,Xuewei Ding MD,Yi Pan MD,Xiangyu Liu MD.Enhancement the Prediction of Postoperative Survival in Gastric Cancer by Combining the Negative Lymph Node Count with Ratio Between Positive and Examined Lymph Nodes[J]. Annals of Surgical Oncology . 2010 (4)
  • 10Yoichiro Homma MD,Shinichiro Ushida MD,Makoto Yamada CT,Hiroshi Kobayashi MD, PhD,Kazufumi Suzuki MD.Positive Peritoneal Washing Cytology in Multiple Cavities Can Predict Poor Prognosis of Advanced Gastric Cancer Patients[J]. Annals of Surgical Oncology . 2010 (2)

共引文献153

同被引文献197

引证文献20

二级引证文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部